Five groups of potential target molecules for antibodies in cancer treatment have been pointed out in recent reviews: cancer cells inside solid tumors, which are less treatable; diffusive cancerous cells (leukemia); the stroma associated with the tumor (fibroblasts); and blood vessels associated with the tumor and vascular endothelial growth factors (VEGF) [10, 11]. The gene discussed is VEGFA; the disease is leukemia.